查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1665265

Dura 替代品市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Dura Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球硬脊膜替代品市場規模達到 2.142 億美元，預計 2025 年至 2034 年期間將以 5.4% 的年複合成長率(CAGR) 強勁成長。這一成長軌跡受到醫療技術的不斷進步、對微創手術的偏好日益增加、對神經外科認知的不斷提高人口的擴大以及老齡化人口的擴大。總的來說，這些因素推動了 Dura 替代品在各種醫療應用中的採用。

Dura 替代品市場 - IMG1

生物材料和手術技術的創新大大提高了硬腦膜替代品的性能和品質。現代材料旨在提高生物相容性、耐用性和吸收性，正在提高手術效果並鞏固硬腦膜替代品作為神經外科實踐中必不可少的組成部分的作用。隨著醫療技術的不斷發展，對先進的硬腦膜替代品的需求將會上升，進一步加速市場成長。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 2.142億美元
預測值 3.571億美元
複合年成長率 5.4%

根據產品類型，市場分為生物和合成硬腦膜替代品。生物硬腦膜替代品，來自膠原蛋白和動物組織等天然來源，預計年複合成長率為 5.1%，到 2034 年將達到 2.326 億美元。它們與身體的無縫結合確保了一致的需求，並使其成為外科手術應用中可靠的解決方案。

市場也按應用進行細分，包括神經外科、脊椎外科、創傷和事故修復、術後修復等。預計神經外科領域將達到顯著成長，預計複合年成長率為 5.5%，到 2034 年將達到 1.559 億美元。這些材料對於修復硬腦膜是必不可少的，增強了其在神經外科治療中的關鍵作用。

美國硬膜替代品市場在 2024 年的價值為 7,700 萬美元，預計到 2034 年將以 5% 的複合年成長率成長。這些進步有助於改善手術效果並加速患者康復，進一步支持該地區的市場擴張。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 神經系統疾病盛行率不斷上升
      • 手術技術的進步
      • 提高外科手術認知和採用率
      • 微創手術需求不斷成長
    • 產業陷阱與挑戰
      • 硬腦膜替代品成本高
      • 新興市場產品供應有限
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未來市場趨勢
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

  • 主要趨勢
  • 生物硬腦膜替代物
  • 合成硬腦膜替代物

第6章：市場估計與預測：按材料，2021 – 2034 年

  • 主要趨勢
  • 膠原蛋白類
  • 聚合物
  • 其他材料

第 7 章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 神經外科
  • 脊椎手術
  • 創傷/意外
  • 術後修復
  • 其他應用

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • ACERA SURGICAL
  • B. Braun
  • Baxter
  • Bennett
  • Biosynth
  • Cook Medical
  • DePuy Synthes
  • GUNZE
  • INTEGRA
  • Medprin
  • Medtronic
  • Natus
  • Severn Healthcare Technologies
  • Stryker
  • GORE
簡介目錄
Product Code: 12745

The Global Dura Substitutes Market reached USD 214.2 million in 2024 and is projected to experience robust growth at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This growth trajectory is propelled by ongoing advancements in medical technologies, the increasing preference for minimally invasive procedures, rising awareness of neurosurgical treatments, and the expanding aging population. Collectively, these factors are driving the adoption of Dura substitutes in various medical applications.

Dura Substitutes Market - IMG1

Innovations in biomaterials and surgical techniques are significantly enhancing the performance and quality of dura substitutes. Modern materials, designed for improved biocompatibility, durability, and absorbability, are elevating surgical outcomes and solidifying the role of dura substitutes as essential components in neurosurgical practices. As medical technology continues to evolve, the demand for advanced dura substitutes is poised to rise, further accelerating market growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$214.2 Million
Forecast Value$357.1 Million
CAGR5.4%

By product type, the market is categorized into biological and synthetic dura substitutes. Biological dura substitutes, derived from natural sources like collagen and animal tissues, are anticipated to grow at a CAGR of 5.1%, reaching USD 232.6 million by 2034. These substitutes offer exceptional biocompatibility and reduce risks associated with immune responses or rejection, making them a preferred choice for procedures requiring long-term tissue repair. Their seamless integration with the body ensures consistent demand and establishes them as a reliable solution in surgical applications.

The market is also segmented by application, including neurosurgery, spinal surgery, trauma and accident repairs, post-surgical repair, and others. The neurosurgery segment is expected to register significant growth with a projected CAGR of 5.5%, reaching USD 155.9 million by 2034. The increasing prevalence of neurological disorders and age-related conditions, coupled with the growing frequency of neurosurgical procedures, is driving demand for highly durable and effective dura substitutes. These materials are indispensable for repairing dura mater, reinforcing their critical role in neurosurgical treatments.

The U.S. Dura substitutes market, valued at USD 77 million in 2024, is forecasted to grow at a CAGR of 5% through 2034. The country's advanced healthcare infrastructure, combined with ongoing innovations in neurosurgical methods, including minimally invasive techniques, is fueling the adoption of high-performance, biocompatible substitutes. These advancements are enabling improved surgical outcomes and faster patient recovery, further supporting market expansion in the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of neurological disorders
      • 3.2.1.2 Advancements in surgical techniques
      • 3.2.1.3 Increasing surgical awareness and adoption
      • 3.2.1.4 Rising demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of dura substitutes
      • 3.2.2.2 Limited product availability in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Biological dura substitute
  • 5.3 Synthetic dura substitute

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Collagen-based
  • 6.3 Polymers
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Neurosurgery
  • 7.3 Spinal surgery
  • 7.4 Trauma/accident
  • 7.5 Post-surgical repair
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ACERA SURGICAL
  • 10.2 B. Braun
  • 10.3 Baxter
  • 10.4 Bennett
  • 10.5 Biosynth
  • 10.6 Cook Medical
  • 10.7 DePuy Synthes
  • 10.8 GUNZE
  • 10.9 INTEGRA
  • 10.10 Medprin
  • 10.11 Medtronic
  • 10.12 Natus
  • 10.13 Severn Healthcare Technologies
  • 10.14 Stryker
  • 10.15 GORE